Industry Wire 254

  1. House passes spending package, small victory for hospitals.
  2. Hospitals are being targeted with extortion letters.
  3. Amazon One Medical CEO steps down.
  4. CMS proposes ACA integrity rule that could harm enrollment.
  5. Nashville General CEO resigns following investigation.
  6. Geisinger building $32M cancer center expansion.
  7. AdventHealth names new hospital COO.
  8. Hospital workers killed in medical helicopter crash in Mississippi.
  9. CVS is opening 12 new mini stores half the size of its typical pharmacies.
  10. Women’s health research reveals clues to aging and Alzheimer’s.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Heart Failure January 29, 2026

Telemedicine’s Unintended HF Consequences January 29, 2026

Heart failure telemedicine doesn’t seem to be lining up evidence-based care after a recent Stanford Medicine analysis revealed that remotely-managed HF patients received less diagnostic testing and saw serious dips in guideline-directed medical therapy. With the rising popularity of remote patient management in cardiology, Stanford researchers decided to explore telemedicine’s HF impact by tracking 44 […]

Cardiology Policy January 26, 2026

Women Need Lower LV Thresholds for AV Surgery January 26, 2026

New multicenter data published in JAMA suggests that surgery for aortic regurgitation may need to be done earlier than current guidelines recommend, with lower LV size thresholds and possibly different cutoffs for men and women. Studying several cohorts, researchers followed 808 patients with symptomatic AR and preserved LVEF with a median 7-year follow-up examining mortality […]

Heart Failure January 26, 2026

Advancing Heart Failure Care: Timely Referral and Life-prolonging Strategies with HeartMate 3  Left Ventricular Assist Device January 26, 2026

Excerpt from Article by Dr. Sanjeev Gulati, Radcliffe Cardiology 2025; e1. Heart failure (HF) remains a leading cause of morbidity and mortality globally, and advanced HF  represents a severe stage of the disease affecting more than 64 million people across the world with  rising prevalence.1,2  Most of us are very experienced in the role that […]